CCA
TMO icon

Childress Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Childress Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$726K Sell
1,447
-92
-6% -$44.2K 0.12% 121
2026
Q1 		$757K Buy
1,539
+49
+3% +$26.6K 0.14% 110
2025
Q4 		$864K Buy
1,490
+224
+18% +$127K 0.14% 106
2025
Q3 		$614K Buy
1,266
+248
+24% +$115K 0.11% 132
2025
Q2 		$413K Sell
1,018
-374
-27% -$156K 0.1% 143
2025
Q1 		$693K Buy
1,392
+69
+5% +$37.4K 0.2% 72
2024
Q4 		$688K Sell
1,323
-106
-7% -$58.3K 0.19% 73
2024
Q3 		$884K Sell
1,429
-7
-0.5% -$4.14K 0.24% 68
2024
Q2 		$794K Buy
+1,436
New +$823K 0.22% 70
2024
Q1 		– Sell
-1,479
Closed -$785K – 217
2023
Q4 		$785K Sell
1,479
-193
-12% -$93.4K 0.23% 64
2023
Q3 		$846K Buy
+1,672
New +$891K 0.28% 59
2023
Q1 		– Sell
-1,791
Closed -$986K – 168
2022
Q4 		$986K Sell
1,791
-357
-17% -$189K 0.33% 54
2022
Q3 		$1.09M Buy
2,148
+22
+1% +$12.3K 0.43% 45
2022
Q2 		$1.16M Buy
2,126
+148
+7% +$81.5K 0.46% 41
2022
Q1 		$1.17M Buy
1,978
+166
+9% +$95.4K 0.41% 46
2021
Q4 		$1.21M Sell
1,812
-18
-1% -$11.2K 0.5% 41
2021
Q3 		$1.04M Buy
1,830
+221
+14% +$121K 0.42% 49
2021
Q2 		$811K Sell
1,609
-24
-1% -$11.3K 0.37% 49
2021
Q1 		$745K Buy
1,633
+345
+27% +$165K 0.34% 55
2020
Q4 		$600K Buy
+1,288
New +$604K 0.35% 36

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Childress Capital Advisors's TMO Position: Q2 2026 in Review

Childress Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6% in Q2 2026, selling an estimated $44.2K and leaving 1,447 shares worth $726K. The position accounts for 0.12% of the portfolio, ranked #121.

Childress Capital Advisors first reported a position in TMO in Q4 2020 and has held it in 20 quarters since. The position peaked at $1.21M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Childress Capital Advisors held 1,447 shares of Thermo Fisher Scientific worth $726K as of Q2 2026.
  • Childress Capital Advisors sold 92 Thermo Fisher Scientific shares in Q2 2026, an estimated $44.2K.
  • Thermo Fisher Scientific made up 0.12% of Childress Capital Advisors's portfolio in Q2 2026, its #121 holding.
  • Childress Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 20 quarters since.
  • Childress Capital Advisors's Thermo Fisher Scientific position peaked at $1.21M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.